Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Clinicopathological evaluation of childhood ocular tumors

Gabriela Cavalieri; Vinicius Carriero Lima; Ana Beatriz Toledo Dias; Christina Mastromonaco; Sabrina Bergeron; Julia Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2321. doi:

ARVO Annual Meeting Abstract July 2019

Clinicopathological evaluation of eye removal procedures: a 13-year evaluation

Vinicius Carriero Lima; Gabriela Cavalieri; Ana Beatriz Toledo Dias; Christina Mastromonaco; Sabrina Bergeron; Julia Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):713. doi:

ARVO Annual Meeting Abstract July 2019

A unique recurrent bilateral presentation of oncocytomas of the caruncle

Cameron Oliver; Sabrina Bergeron; Jacqueline Coblentz; Ana Beatriz Toledo Dias; Julia Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3569. doi:

ARVO Annual Meeting Abstract July 2019

Interleukin-1β expression is positively correlated with cyclooxygenase-2 expression in basal cell carcinoma of the eyelid

Patrick Daigle; Myriam MacDonald; Ana Beatriz Toledo Dias; Sabrina Bergeron; Rami Darwich; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3570. doi:

ARVO Annual Meeting Abstract July 2018

The transcription factor SREBP-1 as a novel marker for sebaceous cell carcinoma of the eyelid

Paulina Garcia de Alba Graue; Ana Beatriz Toledo Dias; Denise Miyamoto; Christina Mastromonaco; Prisca Raquel Bustamante; Myriam MacDonald; Julia V Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5603. doi:

ARVO Annual Meeting Abstract July 2018

Histopathological analysis of residual lens cells in capsular opacities after cataract surgery

Christina Mastromonaco; Matthew Balazsi; Ana Beatriz Toledo Dias; Debra-Meghan Sanft; Jade Marie Lasiste; Alessio Cardillo; Jose Joao Mansure; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6015. doi:

ARVO Annual Meeting Abstract July 2018

The relationship between prognostic factors and CD109 expression in uveal melanoma

Jacqueline Coblentz; sabrina bergeron; Ana Beatriz Toledo Dias; Tadgh Ferrier; Juliana Passos; Florence Couvrette; Jose Joao Mansure; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3180. doi:

ARVO Annual Meeting Abstract July 2018

A series of unusual intraocular and orbital metastasis: the importance of immunohistochemistry for the final diagnosis

Ana Beatriz Toledo Dias; Augusto Terra Baccega; Denise Miyamoto; Jacqueline Coblentz; Yasser Althnayan; Vasco Torres Fernandes Bravo Filho; Alexandre Nakao Odashiro; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4327. doi:

ARVO Annual Meeting Abstract June 2017

HER2 as a possible therapeutic target in squamous cell carcinoma of the conjunctiva

Evangelina Esposito; Pablo Zoroquiain; Ana Beatriz Toledo Dias; Flavio Luis Schneider; Sonia Corredor-Casas; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3354. doi:

ARVO Annual Meeting Abstract June 2017

Eyelid Sebaceous Carcinoma and HER2 expression

Alexandre Odashiro; Patricia Odashiro; Ana Beatriz Toledo Dias; Pablo Zoroquiain; Denise Miyamoto; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3361. doi:

ARVO Annual Meeting Abstract June 2017

Eyelid Sebaceous Carcinoma and Program cell death ligand 1 expression

Patricia Odashiro; Alexandre Odashiro; Ana Beatriz Toledo Dias; Pablo Zoroquiain; Denise Miyamoto; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3363. doi:

ARVO Annual Meeting Abstract June 2017

Expression of anaplastic lymphoma kinase in uveal melanoma

Jacqueline Coblentz; Patrick T Logan; Ana Beatriz Toledo Dias; Evangelina Esposito; Jose Joao Mansure; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3955. doi:

ARVO Annual Meeting Abstract June 2017

Programmed cell death ligand 1 expression in uveal melanoma is associated with better patient outcome and decreased tumor infiltrating lymphocytes

Ana Beatriz Toledo Dias; Pablo Zoroquiain; Natalia Vila Grane; Ana Carolina Dias-Reis; Patrick T Logan; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4416. doi:

ARVO Annual Meeting Abstract June 2017

Clinicopathological analysis of Juvenile Xanthogranuloma: A 10-year review

Rafael Frederico Peres; Rafael Reis Pereira; Sérgio Burnier; Ana Beatriz Toledo Dias; Patrick T Logan; Aaron I Rosen; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2419. doi:

ARVO Annual Meeting Abstract September 2016

Investigating Maspin Expression in Ocular Surface Squamous Neoplasia

Silvin Bakalian; Pablo Zoroquiain; Ana Beatriz Toledo Dias; Dina Abdulmannan; Patrick Logan; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2411. doi:

ARVO Annual Meeting Abstract September 2016

The differences in expression of HMB 45, Melan A and COX 2 in canine and human uveal melanoma

Evangelina Esposito; Paulo S M Barros; Eduardo Perlmann; Erin Mayo-Goldberg; Ana Beatriz Toledo Dias; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4110. doi:

ARVO Annual Meeting Abstract September 2016

Expression of SIRT1 in a Uveal Melanoma Animal Model

Debra-Meghan Sanft; Christina Mastromonaco; Ana Beatriz Toledo Dias; Maria Silvia Burnier; Shawn C Maloney; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4112. doi:

ARVO Annual Meeting Abstract September 2016

Immunohistochemical profile of keratoconic corneas

Marcelo Sobrinho; Sultan Aldrees; Pablo Zoroquiain; Patrick Logan; Ana Beatriz Toledo Dias; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4897. doi:

ARVO Annual Meeting Abstract September 2016

Spleen tyrosine kinase as an ultra violet damage marker in the conjunctiva and choroid of normal human eyes and eyes harboring uveal melanoma

Marcela Bohn; Christina Mastromonaco; Patrick Logan; Ana Beatriz Toledo Dias; Sultan Aldrees; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5889. doi:

ARVO Annual Meeting Abstract September 2016

Programmed cell death ligand 1 expression in uveal melanoma is associated with better patient outcome

Pablo Zoroquiain; Ana Beatriz Toledo Dias; Patrick Logan; Sultan Aldrees; Evangelina Esposito; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5893. doi:

1 2

Next 20 Results »

Advertisement